The Bachelor of Chemical and Biopharmaceutical Engineering (Honours) at Munster Technological University focuses on innovative process design and control to develop life-enhancing products. The program emphasizes applying scientific and mathematical principles to transform raw materials into pharmaceuticals, energy solutions, and environmental technologies, preparing students to lead advancements in these critical sectors.
Not enough reviews to generate pros and cons
The Bachelor of Chemical and Biopharmaceutical Engineering (Honours) at Munster Technological University focuses on innovative process design and control to develop life-enhancing products. The program emphasizes applying scientific and mathematical principles to transform raw materials into pharmaceuticals, energy solutions, and environmental technologies, preparing students to lead advancements in these critical sectors.
Not Available in Not Available
400 Students
AI/ML, Systems, Theory, Human-Computer Interaction
Access to cutting-edge research labs and industry partnerships
80.0
Starting 2026-09-01
Apply before 2125-04-18
Starting 2025-09-01
Apply before 2125-04-18
Feb-26
Courses included:Biopharmaceutical EngineeringProcess Energy AnalysisEquilibrium SeparationsEquipment DesignChemical Reactor Engineering
No academic requirements found.
Applicants must meet the general admission criteria, including a Leaving Certificate with at least six subjects: two at H5 grade and four at O6/H7 grades, with Mathematics included at a minimum of H4 grade. Proficiency in English or Irish is also required, ensuring students possess the foundational skills necessary for rigorous scientific study.
₹14,07,375/Year
Annual Fee
4 years
Total Duration
No Living costs available.
No University Scholarships Available
N/A
Amount
1250 USD
Deadline
Not specified
N/A
Amount
Various benefits
Deadline
Not specified
N/A
Amount
Various benefits
Deadline
Not specified
N/A
Amount
2000 USD
Deadline
15 Apr 2025
N/A
Amount
300 EUR
Deadline
Anytime
No Eligibility Requirements Available
No Application Steps Available
No news articles found